Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.

NCT07068490 · clinicaltrials.gov ↗

RECRUITING

Status

100000

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Routine use of P-CAB on DAPT
DRUG: Guideline Directed Medical Therapy

Sponsor

Samsung Medical Center